Congratulations to Diego Velarde
PhD student and CaRE2 trainee Diego Velarde just got funded by a supplement to Dr. Offringa’s R21 CA290319 aimed at studying the effect of single nucleotide polymorphisms on lung cancer in Black/African American individuals. The supplement will allow Diego to expand his lung cancer research to include a focus on cancer health disparities.
CaRE2 Takes the Lead at AACR CHD Conference
Heard the news? Not only are we attending AACR’s Conference on the Science of Cancer Health Disparities this year, but our center is taking a huge leadership role! 🙌 In recognition of their innovation in cancer health disparities research, several of our center members have been appointed Program Committee members and Conference Co-Chairs for this […]
Matthew Gregory Travel Report
Travel Report: USC Visitation Start: August 2, 2022 End: August 10, 2022 Location: USC/Norris Cancer Center Laboratory: Dr. Ite Offringa Attendee: Matthew D. Gregory Lab Experience August 2, 2022, served as a travel day, arrival in LA was later than expected due to delays. The following days (August 3-4th) were used to acclimate to the lab […]
CaRE2 @ Taste of Soul Event
On Saturday, October 15, 2022, the USC Norris Comprehensive Cancer Center Office of Community Outreach & Education (COE) Associate Director, Dr. Lourdes Baezconde-Garbanati and team were present at the 2022 Taste of Soul (TOS) event. The USC NCCC Office of COE, along with representation from CaRE2 Health Equity Center, disseminated cancer and clinical trials educational […]
April 2022 Webinar
Dr. Ademola A. Popoola is a Urologist who works at the University of Ilorin, Nigeria. He has interest in urologic malignancies especially prostate and kidney cancers. He is the zonal coordinator for Transatlantic Prostate Cancer Consortium and currently the Nigerian National PI for International Registry of Men with Advanced Prostate Cancer (IRONMAN). Dr. Popoola is […]
CaRE2 MPI, John Carpten, selected to chair the Biden administration’s National Cancer Advisory Board
CaRE2 leader, John Carpten, was present at the White House for the announcement of the Biden administration’s renewal of the Cancer Moonshot program that aims to reduce the national death rate from cancer by 50% in the next 25 years. Moreover, Dr Carpten was appointed as the chair of the of the National Cancer Advisory […]
The CaRE2 Health Equity Center Celebrates Black & Women’s History Month with a focus on Trainees
The CaRE2 Health Equity Center is proud to announce our joint celebration of Black and Women’s History Month focusing on the center’s Trainees and Early Stage Investigators (ESIs). Please join us for a program where we introduce our trainees, and hear about exciting new research by this next generation of cancer health disparities researchers. https://usc.zoom.us/j/92191103681?pwd=TklGeFljMFVIVVRiR3JtLzJyck5EUT09 […]
Dr Jamel Ali, CaRE2 ESI Receives AFOSR Award
CaRE2 ESI, Dr Jamel Ali earns first ever award from Air Force Office of Scientific Research to a Historically Black Collage and University.
FDA Approval
Nature Medicine Publication
CaRE2 founding partner Dr. Folake Odedina and Co-MPI Dr Mariana Stern published a piece in Nature Medicine about the role of funders in improving representation of underrepresented minority scientist in research. It is part of a series of commentaries on this issue of the magazine as they launch a new series on Diversity, Equity and […]
